Latest news
REPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - StocktwitsStocktwits · Sat, 08 Aug 2026 03:13:33 GMTAfter two rejections and mass layoffs, Replimune melanoma drug wins FDA approval - The Business JournalsThe Business Journals · Thu, 06 Aug 2026 21:13:00 GMT